AZD8186, a potent and selective inhibitor of PI3Kβ/δ, as monotherapy and in combination with abiraterone acetate plus prednisone (AAP), in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | de Bono, J. S.; Hansen, A.; Choudhury, A. D.; Cook, N.; Heath, E. I.; Higano, C.; Linch, M.; Martin-Liberal, J.; Rathkopf, D. E.; Wisinski, K. B.; Barry, S.; de Bruin, E.; Brugger, W.; Colebrook, S.; Klinowska, T.; Moschetta, M.; Mortimer, P. G. S.; Siu, L. L.; Shapiro, G. |
| Abstract Title: | AZD8186, a potent and selective inhibitor of PI3Kβ/δ, as monotherapy and in combination with abiraterone acetate plus prednisone (AAP), in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy284.042 |
| Language: | English |
| ACCESSION: | WOS:000459277302015 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy284.042 |
| Notes: | Meeting Abstract: 833P -- Appears on pages viii291-viii292 of the abstract book -- Source: Wos |
